Detection of Patients With Abnormal Water Distribution Based on Bioelectrical Impedance Analysis (BIA)

Completed

• Conditions: Kidney Diseases

• Registration Number: NCT01481311
• Lead Sponsor: Seca GmbH & Co. Kg.

Brief Summary

The aim of this clinical investigation is to prove that the seca mbca detects dialysis patients with abnormal water distribution correctly. Abnormal high water distribution is defined as more than 2 liters of Total Body Water (TBW) above a normal value range. TBW and Extra Cellular Water (ECW) are calculated with prediction equations for healthy subjects generated in BCA-01. The results are compared with TBW and ECW ascertained by dilution methods as standard reference methods. The Bioelectrical Impedance Analysis (BIA) method should be evaluated to the accuracy of the absolute measurement of the volume state of dialysis patients (euvolaemic and hypervolaemic) based on a single measurement.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2011-11-10
• Study First Submitted QC: 2011-11-23
• Study First Posted: 2011-11-29
• Study Start: 2012-01
• Primary Completion: 2012-08
• Study Completion: 2012-08
• Status Verified: 2012-10
• Last Update Submitted: 2012-10-02
• Last Update Posted: 2012-10-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 62

Inclusion Criteria

The study will cover 50 adults. Men and women in an age range of 18 to 65 years and a Body Mass Index (BMI) range of 18.5 to 35 kg/m2 should be equally distributed. Subjects have to be patients with chronic kidney failure taking dialysis treatment. 25 patients are taken before and another 25 patients after this treatment. Patients that are taken before dialysis treatment should have been dialysed two and not three days before.

Exclusion Criteria

• amputation of limbs
• gastrointestinal tract illnesses that influence the absorption of substances that are needed for dialysis
• bed-ridden patients patients with clinical relevant hypervolaemia or hypovolaemia
• electrical implant as cardiac pacemaker
• insulin pumps
• pregnancy or breastfeeding period
• subjects who cannot provide an Informed Consent Form (ICF) by themselves
• subjects who might be dependent from the sponsor or the investigation site

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bioelectrical impedance (Resistance and Reactance) of 5 and 50 kHz for the right body side	about 2 minutes	The measurements are utilized as input for prediction equations to calculate TBW and ECW.

Secondary Outcome Measures

Name	Time	Method
Bioelectrical impedance (Resistance and Reactance) of 1, 1.5, 2, 3, 7.5, 10, 15, 20, 30, 75, 100, 150, 200, 300, 500, 750 and 1,000 kHz	about 2 minutes	The measurement is planned to be done for all body segments: right arm, left arm, right leg, left leg, trunk, right body side and left body side. In total resistance and reactance at 19 frequencies for 7 body segments are to be measured.
TBW	within 4 hours	A D2O dose of 400 mg per kg body weight mixed with tap water is administered orally in the morning fasting and after a 2 hour fluid abstention. The distribution of the stable isotope in the TBW is completed after 4 hours. During this period, the subject remains fasting. Two venous blood samples of 10 ml whole blood are taken immediately before and four hours after taking D2O. The plasma samples are analyzed using Isoptopic Ratio Mass Spectrometry (IRMS).
ECW	within 4 hours	Orally administered NaBr is resorbed quickly and completely and almost exclusively distributes in the extracellular compartment. Blood samples of 10 ml are taken immediately before and 4 hours after oral application of 50 mg NaBr per kg body weight. The serum sample is analyzed by X-Ray Fluorescence Spectroscopy (XRF).

Trial Locations

Locations (1)

Charité University Medicine Berlin; 🇩🇪 Berlin, Germany